Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/Fine Chemicals Roundup – November 8
5:39 AM MST | November 8, 2011 | Deepti Ramesh
CAMBREX SWINGS TO PROFIT Cambrex (East Rutherford, NJ) reported net profits of $2.76 million for the third quarter ended September 30, 2011, compared with a net loss of $1.45 million in the year-ago period. Net sales for the quarter increased 18%, to $57.8 million. The rise in sales is primarily due to higher sales of an active pharmaceutical ingredient (API) to a customer who experienced a disruption in its supply chain for most of 2010; higher volumes of controlled substances; and increased volumes of products utilizing Cambrex’s drug delivery technology...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee